This study is currently not recruiting participants.

Phase II Study of Paclitaxel for Ovarian Stromal Tumors as Second-line Therapy

Investigation of an Investigational Medication for Cancer Study

Not Recruiting
18 years - 100 years
Female
Phase N/A

Brief description of study.

The purpose of this study is to determine if paclitaxel will cause my cancer to completely disappear at all sites and all places where cancer has been detected.

Detailed description of study

The purpose of this study is to determine if paclitaxel will cause my cancer to completely disappear at all sites and all places where cancer has been detected.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Ovarian Cancer
  • Age: 18 years - 100 years
  • Gender: Female

The purpose of this study is to investigate if an investigational medication can make cancer disappear completely at all sites where it has been detected. Cancer is a disease where cells in the body grow uncontrollably and spread to other parts of the body.

In this study, participants will receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine. The study will include regular monitoring to assess the effects of the treatment.

  • Who can participate: Eligibility criteria are not specified in the provided information. Please contact the study team for details on age and key eligibility factors.
  • Study details: Participants will be randomly assigned to receive either the investigational medication or a placebo. A placebo is an inactive substance that looks like the investigational medication but does not contain any medicine.
Updated on 19 Feb 2024. Study ID: 1109006641

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team